In this episode, Dr. Alex Terrazas sits down with Dr. David Wolinsky, MD, Assistant Professor of Psychiatry at Johns Hopkins University School of Medicine and researcher with the Johns Hopkins Cannabis Science Lab. Dr. Wolinsky specializes in Addiction Psychiatry, focusing on Cannabis Use Disorder and Cannabis Withdrawal Syndrome.

This is a must-listen for any adult cannabis consumer — especially boomers returning to cannabis after decades away, or trying it for the first time.

What You'll Learn:

• What cannabis-induced psychosis actually looks like — and how it differs from anxiety or paranoia
• How cannabis affects the same brain regions implicated in schizophrenia
• The chicken-and-egg causality debate: does cannabis cause psychosis, or do people prone to psychosis seek out cannabis?
• Why today's high-potency THC products are a completely different experience than cannabis from the 60s, 70s, or 80s
• Which route of administration — smoking, vaping, or edibles — carries the most psychosis risk, and why edibles send a disproportionate number of people to the ER
• The critical drug-drug interactions between CBD and common medications like warfarin
• How to tell if high-CBD or low-THC products are actually safer from a psychiatric standpoint
• What to do if you or someone you know has a bad cannabis episode
• What cannabis use disorder looks like in older adults — and why it's likely underdiagnosed
• Cannabis and neurodegenerative diseases: Alzheimer's, Parkinson's, and Huntington's
• Dr. Wolinsky's take on legalization, rescheduling, and the future of cannabis research

Guest: Dr. David Wolinsky, MD Assistant Professor of Psychiatry, Johns Hopkins University School of Medicine Johns Hopkins Cannabis Science Lab

Connect with Cannabis Boomer: 🌐 cannabisboomer.com 📧 cannabisboomer@gmail.com 📸 Instagram: @CannabisBoomer 🐦 X: @CannabisBoomer

The Cannabis Boomer Podcast covered various topics in 2025, including cannabis use for sleep, pain, migraines, and its effects on older adults and pets. The podcast also explored unexpected topics like female sexual function and sleep apnea. Looking ahead to 2026, the podcast will focus on questions surrounding cannabis rescheduling, banking regulations, and the potential for Medicare coverage of cannabis therapies.

#cannabis #cannabisboomer #marijuana #THC #CBD #CBN #medicalmarijuana #cannabisresearch #cannabisnews #2025review #yearinreview #cannabislegalization #rescheduling #Schedule3 #cannabislaw #cannabisindustry #olderadults #seniors #babyboomer #healthyaging #chronicpain #sleep #insomnia #anxiety #migraine #cannabisscience #endocannabinoidsystem #terpenes #edibles #cannabisbeverages #veterinarycannabis #CBDforpets #cannabispolicy #TrumpExecutiveOrder #SAFERBankingAct #cannabistesting #cannabissafety

#CannabisMovies #StonerComedyHistory #CannabisCinema #MarijuanaInFilm #CannabisCounterculture #StonerMovieClassics #CannabisFilmHistory #Top10CannabisMovies #MarijuanaCultureMovies #CannabisCinematicHistory

#cannabismovies #stonerfilms #marijuanacinema #cannabisculturemovies #bestweedmovies #HaroldandKumar #TheBigLebowski #Fridaymovie #FastTimesatRidgemontHigh #InherentVice #cannabisfilmhistory #stonercomedy #marijuanalegalizationmovies #cannabiscultureevolution #drugwarmovies #counterculturecinema #1970scannabismovies #cannabisrepresentation #AsianAmericanstonercomedy #Blackcannabisculture #cannabisdocumentary #marijuanaactivismfilms #Reaganerapolicy #cannabisdecriminalization #weedmovierecommendations #cannabisboomerpodcast #cannabiseducation #marijuanaculturedocumentary #JeffBridges #TheDude #IceCube #ThomasPynchon #cannabissocialjustice #drugpolicycinema #marijuanastereotypes #cannabisholidaymovies #top10cannabisfilms #cannabismoviereviews #marijuanapopculture #cannabisconsciousness

Cannabis portrayals in media have evolved over time, reflecting societal attitudes. Initially depicted as a threat to social order, cannabis transitioned to a symbol of counterculture in the 60s and 70s. By the 80s and 90s, it became a comedic trope, and in recent years, it is increasingly portrayed as a legitimate industry.

The normalization of cannabis use is increasing due to its availability in dispensaries and online, as well as its portrayal in media. Despite this, persistent myths about cannabis, such as the stoner archetype and its association with deviating from the mainstream, remain. The stigma surrounding cannabis use continues to hinder its acceptance for medical purposes, despite its potential benefits.

Cannabis Boomer podcast aims to educate users about cannabis and its effects, emphasizing the importance of informed consumption. The information shared is based on current scientific opinion and should not be considered medical advice.

#CannabisHistory, #MarijuanaMediaPortrayal, #DrEmilyDufton, #ReeferMadnessHistory, #CannabisLegalizationTimeline, #StonerStereotypeOrigins, #HarryAnslingerCannabis, #CannabisDecriminalization1970s, #MedicalMarijuanaHistory, #CannabisSocialMovements

Cannabis use, particularly smoking, generally leads to compensatory driving behaviors like reduced speed and lane changes, resulting in a lower accident risk compared to alcohol. However, edibles, with their delayed onset and stronger psychoactive effects, pose a greater risk, and users are advised to utilize a taxi or have a designated driver if they consume edibles. Combining cannabis and alcohol can have synergistic adverse effects on psychomotor performance, making it particularly dangerous.

Rescheduling cannabis from Schedule I to Schedule III would acknowledge its medical utility but wouldn’t address the conflict between federal and state laws. Descheduling cannabis from the Controlled Substances Act is necessary for states to regulate it independently. NORML continues to advocate for cannabis reform, fighting against efforts to undermine existing policies and holding the line to protect the rights of responsible adults and patients.

Cannabis Boomer podcast aims to educate users about cannabis and its effects, emphasizing the importance of informed consumption. The information shared is based on current scientific opinion and should not be considered medical advice.

Primary Keywords: #CannabisAndDriving #MarijuanaLaws #CannabisSafety #THCImpairment #NORMLAdvocacy #MedicalMarijuana #CannabisPolicy #ResponsibleUse #DrivingUnderTheInfluence #CannabisScience

Secondary Keywords: #CannabisReform #MarijuanaLegalization #THCBloodLevels #EdiblesAndDriving #CannabisEducation #WeedSafety #PaulArmentano #CannabisResearch #MarijuanaTesting #DrugPolicyReform

Topical Keywords: #CannabisBoomer #Over50Cannabis #SeniorCannabis #EvidenceBasedPolicy #CannabisAdvocacy #Rescheduling #Schedule3 #CBDSafety #EndocannabinoidSystem #VeteransCannabis

Long-tail Keywords: #HowLongAfterSmokingCanIDrive #CannabisPsychomotorEffects #THCMetabolites #AlcoholAndCannabis #CompensatoryDriving #CannabisVsAlcoholDriving

Clinical endocannabinoid deficiency, characterized by low levels of anandamide and 2-AG, may contribute to migraine, fibromyalgia, and irritable bowel syndrome. Restoring 2-AG levels can alleviate migraine symptoms, while depleting it can induce headaches. Cannabis, particularly strains with higher THC content, may be effective for migraine relief, but it’s crucial to consult a physician and purchase from regulated dispensaries for safety and efficacy.

Microdosing cannabis could be an effective preventative strategy for migraine headaches, though it may not be effective for reversing headaches once they occur. Many clinicians lack formal education on cannabis and its potential interactions with other medications, making it challenging for patients to receive informed recommendations. Researchers face challenges in conducting cannabis research due to its Schedule I status, but there are avenues for obtaining cannabis for research purposes.

The majority of cannabis research still relies on government-supplied compounds, but the field is opening up to include pure forms of THC and CBD. Rescheduling cannabis to Schedule III would facilitate research but could complicate patient access due to stricter regulations and potential pharmacy limitations. Future research will explore the interaction between cannabis, hormones, and environmental factors like microplastics, as well as the potential for migraines in other species.

Primary Topics #migraine #migrainerelief #cannabisformigraine #medicalcannabis #endocannabinoidsystem #chronicpain #headacherelief #migraineawareness

Scientific/Medical Terms #endocannabinoiddeficiency #anandamide #2AG #cannabinoidreceptors #THC #CBD #pharmacology #neuroscienceresearch #painresearch

Condition-Related #chronicmigraine #migrainewithAura #clusterheadache #medicationoveruse #hormonalheadache #womenshealth #painmanagement

Cannabis Education #cannabiseducation #cannabisscience #cannabisresearch #medicalmarijuana #cannabinoids #entourageeffect #microdosing #terpenes

Audience/Lifestyle #cannabisboomer #over50wellness #seniorsandcannabis #cannabiscommunity #plantmedicine #holistichealth #alternativemedicine

Guest/Institution #UniversityofArizona #DrTallyLargentMilnes #painscience #cannabispodcast

#CannabisPatents #CannabisIndustry #CannabisResearch #CannabisTherapeutics #CannabisDelivery #CannabisInnovation #CannabisScience

Teresa Hansen, a former research and development chef at Starbucks discusses everything that's new in cannabis edibles and emphasizes the importance of thorough research and development in creating shelf-stable baked goods with consistent cannabis concentrations. She advises new consumers to start with a low dose and gradually increase it to find their ideal experience. Safety is a top priority at Copperstate, with child-resistant packaging and proper labeling being essential to prevent accidental consumption.

The cannabis industry is seeing a growing interest in beverages, with a focus on low-dose options and unique extraction processes like rosin-based gummies and chocolates. These products often incorporate a variety of cannabinoids, such as CBD and CBN, to create different effects and cater to consumer preferences. While terpenes may lose some potency in edibles, the full-spectrum nature of these products can still provide a unique experience.

The Cannabis Boomer Podcast is not just for baby boomers and older adults, but for all adults interested in cannabis and health.

#cannabis #edibles #THC #CBD #CBN #cannabisboomerpodcast #health #wellness

For this particular episode, key words are: cannabis, female orgasm difficulty and disorder, female orgasm, sex, marijuana, THC, CBD, CBN, and women's health.

Dr. Suzanne Mulvehill, a clinical sexologist, discusses the intersection of cannabis and female sexual function, particularly Female Orgasmic Disorder. She highlights the misconceptions surrounding cannabis as a drug rather than a medicine and emphasizes the need for research on its potential benefits for sexual health. Dr. Mulvehill explains how cannabinoids interact with the endocannabinoid system, influencing sexual response, and emphasizes the importance of self-experimentation in finding the right cannabis dosage for individual needs.

Cannabis can help women with orgasm difficulties by quieting cognitive distractions and allowing them to focus on sensations. However, finding the right dosage and method of use is crucial, as too much or too little can inhibit function. Dr. Suzanne Mulvehill and her research partner are developing a training program for doctors and therapists to guide women in using cannabis for sexual issues.

Dr. Suzanne Mulvehill discusses the prevalence of orgasm difficulties in women, highlighting that up to 72% of premenopausal women experience this issue. She explores the potential benefits of cannabis in enhancing sexual experiences, referencing historical rituals and the increasing prevalence of orgasm difficulties in the DSM-5. Dr. Mulvehill emphasizes the need for further research on the effects of cannabis on different types of female orgasms.

Podcast aims to inform cannabis users about cannabis and its effects, emphasizing the information is not medical advice.

#CannabisPodcast #FemaleOrgasm #CannabisAndSex #SexualWellness #FemaleOrgasmicDisorder #WomenHealth #SexualHealth #MedicalCannabis #CannabisResearch #THC #Endocannabinoid #SexTherapy #OrgasmDifficulty #WomensHealth #CannabisEducation #SexualDysfunction #PleasurePractice #CognitiveDistraction #CannabisMedicine #SexResearch #FemaleHealth #IntimateWellness #CannabisBoomer #DrSuzanneMulvehill #OrgasmHour #SexualMedicine #CannabisBenefits #WomenAndCannabis #SexualResponse #MindBodyConnection

For this particular episode, key words are: cannabis, sleep science, marijuana, THC, CBD, CBN, REM. non-REM, and sleep.

Cannabis, particularly THC, alters sleep architecture by increasing non-REM sleep and decreasing REM sleep. While this may be beneficial for conditions like PTSD or insomnia, it could be detrimental for healthy individuals as REM sleep is crucial for learning and memory. The effects of cannabis on sleep diminish over time due to tolerance, and the method of consumption may also impact sleep quality.

Dr. Andrew Kesner discusses his research on cannabis and sleep, particularly focusing on sleep disruption as a withdrawal symptom. He highlights the need for more research on cannabis and sleep, emphasizing the importance of studying sex differences. While acknowledging the potential benefits of cannabis for sleep, he emphasizes the need for further research to understand its effects and potential risks.

The effects of cannabis on sleep are complex and multifaceted, influenced by factors like preexisting pain, anxiety, and age. Animal studies, particularly those using mice, are crucial for understanding the specific brain pathways and mechanisms involved, as they allow for controlled experiments and the use of sophisticated genetic tools. While human studies often rely on self-reported measures, animal research can utilize EEG recordings to provide a more detailed and objective analysis of sleep architecture and quality.

Dr. Isobel Lavender discusses the complexity of studying cannabis and sleep, highlighting the diverse effects of different cannabinoids and the variability in sleep patterns among individuals. She emphasizes the need for consistent research methods and doses to better understand the impact of cannabis on sleep, particularly in relation to sleep disorders like insomnia. Lavender also explores the potential benefits of CBN for reducing sleep onset latency.

Primary Keywords: #CannabisAndSleep #SleepScience #THC #CBD #CBN #Cannabinol #REMSleep #NonREMSleep #SleepArchitecture #MedicalCannabis #CannabisResearch #SleepMedicine

Secondary Keywords: #Insomnia #SleepDisorders #SleepQuality #Cannabinoids #EndocannabinoidSystem #SleepHealth #DeepSleep #SleepOnset #SleepHygiene #NaturalSleep

For this particular episode, key words are: cannabis, obstructive sleep apnea, marijuana, THC, CBD, and sleep.

A systematic review of the literature on the use of cannabinoids to treat obstructive sleep apnea found only nine unique records, indicating a lack of evidence in this area. While some positive findings were reported, such as improvements in symptoms and a reduction in APNIC episodes, 80% of participants experienced side effects. The hypothesized physiological mechanisms underlying the effects of cannabinoids on obstructive sleep apnea involve endocannabinoids activating CB receptors, potentially improving sleep quality and circadian rhythm.

The review found limited research on the use of cannabinoids for treating obstructive sleep apnea (OSA). While some promising results were observed, the short duration of existing studies (median of three weeks) highlights the need for longer-term randomized controlled trials to better understand the potential benefits and risks of cannabis use for OSA patients. The American Academy of Sleep Medicine currently recommends against using cannabinoids for OSA, but some states, like Minnesota, have included it as a medical indication.

For this particular episode, key words are: cannabis, baby boomers, older adults, marijuana, THC, CBD, and public health

Baby boomers and older adults are increasingly using cannabis, posing a public health risk due to their vulnerability to health issues like cognitive decline and falls. Studies show that older adults, particularly baby boomers, often smoke cannabis, a method associated with higher health risks, and tend to use it in the afternoon and nighttime, increasing the risk of impaired driving. While many claim to use cannabis for medical reasons, it is often used for self-treatment of mental health conditions, rather than approved medical indications.

The relationship between cannabis legalization and opioid use is complex and inconclusive, with mixed results from studies. While some research suggests cannabis may reduce opioid use, others indicate it could increase the risk of substance use disorders. Older adults, particularly those over 65, face unique vulnerabilities related to cannabis use due to biological factors and potential interactions with medications.

Cannabis use among baby boomers and older adults is increasing, often for general wellbeing rather than specific medical conditions. However, the evidence supporting cannabis’s health benefits, particularly for cognitive function, is sparse. To minimize risks, older adults should limit cannabis use, avoid potent products like concentrates, and be mindful of potential impairments, especially when engaging in activities like driving.

For this particular episode, key words are: marijuana rescheduling, marijuana descheduling, cannabis law, and cannabis business law.

Cannabis legal expert Janet Jackim discusses the potential implications of rescheduling cannabis from a Schedule One to a Schedule Three controlled substance. While rescheduling could increase profits for cannabis businesses by allowing tax deductions, it could also lead to increased regulation and restrictions for consumers. The process of rescheduling is complex and involves various governmental agencies, making the future of cannabis legalization uncertain.

Rescheduling cannabis to Schedule Three would require human and animal testing, potentially impacting medical patients and existing state programs. Descheduling would eliminate federal prosecution but likely maintain laws against trafficking and cartel activity. While rescheduling could boost research and industry partnerships, it might also lead to overproduction, price compression, and business closures, favoring consolidation and specialized businesses.

To contact Jane Jackim email her at jjackim@fennemore.com.

For this particular, episode key words are: cannabis and marijuana testing, marijuana consumer protections, and cannabis business law.

The cannabis industry faces challenges in consumer protection due to the nature of cannabis as an “experienced good,” where quality can only be determined after consumption. This creates a situation of asymmetric information, where manufacturers know the product quality but consumers do not. Experts highlight issues such as inaccurate labeling, fraudulent testing practices, and the need for improved regulations and consumer protections.

Cannabis testing fraud is a significant issue, with inflated THC percentages and pesticide contamination being common problems. The lack of proper regulations and oversight allows labs to manipulate test results, benefiting cannabis companies at the expense of consumers. To address this, a system like METRC could be used for batch testing at the shelf, eliminating the business relationship between labs and cannabis companies.

There is a lack of sophisticated reviewing of cannabis products, with many reviews being overly positive and lacking professionalism. Concerns are raised about the use of organic pesticides, such as neem oil, which can be harmful when used on cannabis plants. Choosing cannabis products can be challenging, especially for those unfamiliar with the market, and it is important to consider trusted brands and packaging regulations.

Overtaxing the cannabis industry can drive consumers back to the black market, undermining the benefits of legalization. States like Missouri, with lower taxes, demonstrate a thriving market, while high-tax states like those on the West Coast face challenges. The cannabis industry is complex, involving medicine, recreation, and various product categories, making regulation difficult.

Cannabis Boomer podcast aims to educate users about cannabis and its effects, emphasizing the importance of informed consumption.The Cannabis Boomer interviews a diverse panel on consumer protections in the cannabis industry.

 Dr. Ruth Fisher PhD is an economist and cannabis industry expert. She is Co-founder of CannaDynamics. Dr. Fisher is the co-author of The Medical Cannabis Primer: Ushering in the Golden Age of Marijuana.

 Ryan Carlisle is a senior banking consultant to the cannabis industry and one of the first bankers in that industry. Ryan has over 10 years’ of specialty banking experience supporting cannabis businesses. Prior to his banking career, he worked in both medical and adult recreational cannabis businesses.

Trent Hancock is a grower with 30 years of experience and a frequent commenter on consumer fraud in the cannabis industry.Trent is a passionate advocate for cannabis testing reform.

Jeff Rawson, PhD is a Harvard-trained biochemist and founder of the Institute of Cannabis Science. The Institute of Cannabis Science aims to normalize cannabis with labels that accurately report contents.

Chapters in this episode include:

00:00:10 Introduction: Consumer Protection in Cannabis with Four Experts

00:01:27 Dr. Ruth Fisher: Cannabis as an Experience Good & Information Asymmetry

00:03:48 Ryan Carlisle: Banking Perspective on Testing Fraud

00:05:39 Trent Hancock: 30-Year Grower Exposes Testing Manipulation

00:06:57 Dr. Jeff Rawson: From EVALI Victim to Consumer Advocate

00:08:08 Personal Stories: Why These Experts Fight for Cannabis Safety

00:09:38 THC Fraud: Why 30% THC Claims Are Impossible

00:11:42 What Testing Should Look Like: Solutions & Standards

00:13:46 METRC System: How Technology Could Fix Testing

00:16:21 The Coming Litigation Tsunami in Cannabis

00:17:59 How Consumers Can Protect Themselves

00:19:24 Choosing Cannabis: Trust Your Nose vs Lab Results

00:22:35 Why Accurate Testing Matters for Legalization

00:24:19 Green Tax: Why Cannabis Businesses Struggle

00:27:56 Regulatory Failures: 80% Effective Tax Rate

00:31:10 How Consumers Actually Choose: THC Numbers & Cool Names

00:34:13 Rescheduling vs Descheduling: What's Coming Next

00:34:53 Conclusion & Consumer Safety Resources

For this particular episode, key words are: cannabis, pets, marijuana, THC, CBD, dogs, cats, and verterinary science.

Cannabis, particularly CBD, shows promise in treating certain conditions in pets, such as seizures, pain, and atopic dermatitis. However, research is limited, and THC is generally not recommended due to dogs’ higher sensitivity to its intoxicating effects. If a pet ingests cannabis, it’s crucial to seek veterinary advice, as supportive care may be necessary.

Cannabis can benefit pets similarly to humans, helping with issues like inflammation, osteoarthritis, seizures, anxiety, sleep, and gastrointestinal disorders. While THC can be beneficial, caution is advised due to dogs’ sensitivity to its intoxicating effects. Legal considerations for cannabis use in pets vary by state, and it’s crucial to seek guidance from a veterinarian knowledgeable about cannabis to avoid accidental harm.

Dr. Gary Richter, a veterinarian, discusses the differences between human and veterinary medicine, emphasizing the importance of quality of life in veterinary care. He highlights the potential benefits of cannabis for pets, particularly in managing pain and improving quality of life. Dr. Richter has authored several books on pet health, including “The Ultimate Pet Health Guide,” which dedicates a chapter to cannabis use in pets.

For this particular episode, key words are: cannabis, pain management, marijuana, THC, CBD, and neuropathic pain.

Dr. Wayne Carter, a clinical toxicology researcher, discusses his recent review on the efficacy of cannabis-based medicines for treating neuropathic pain. The review, published in Biomolecules, analyzed 22 studies and found significant pain reduction in 15 of them. While acknowledging the limitations of randomized controlled trials, Dr. Carter emphasizes the potential of cannabis as a pain treatment, particularly for those unresponsive to traditional medications.

For this particular episode, key words are: cannabis, pain management, marijuana, THC, CBD, terpenes, acute pain, chronic pain, and cannabis testing.

The Cannabis Boomer Podcast discusses cannabis use for pain management, emphasizing it as one tool among many, including exercise and meditation. The episode highlights the importance of understanding pain types, distinguishing between acute and chronic pain, and the effectiveness of cannabis for neuropathic and inflammatory pain. It also explores the role of cannabinoids and terpenes in pain relief, recommending a one-to-one CBD-THC ratio and specific terpenes like beta-caryophyllene and myrcene.

The entourage effect suggests that various compounds in cannabis interact to produce unique effects, but strong evidence for this phenomenon is lacking. Despite this, researchers are investigating individual compounds like terpenes for their potential therapeutic benefits. The cannabis market offers a wide variety of formulations, but the lack of scientific evidence behind many claims highlights the need for further research to support consumer choices.

Cannabis products vary in regulation and testing, with FDA-approved products like Epidiolex being the most regulated. While cannabis can offer pain relief, it’s important to be aware of potential side effects, especially from THC, such as altered mood, dry mouth, and in rare cases, more severe reactions. Combining cannabis with other pain management strategies like exercise, sleep, and a healthy diet can be beneficial, but it should not be the sole approach.

Cannabis, particularly the terpene beta-caryophyllene, shows potential in enhancing opioid analgesia while blocking addiction. However, cannabis products with THC are classified as Schedule I drugs, limiting their legal prescription and research. There is a need for more education on cannabis use in medical curricula, as well as research on its efficacy and safety, especially in pain management.

Research is being conducted on terpenes, focusing on their pain-relieving properties and potential to modulate the effects of other drugs. The study aims to understand the mechanisms behind terpene-induced pain relief and their impact on reward and addiction potential. The research will culminate in a clinical trial to evaluate the effectiveness of terpenes in a scientifically rigorous manner.

The potential of cannabis as a treatment for neuropathic pain is discussed, highlighting the need for further research on mechanisms and identifying responsive patients. A study on medical cannabis use in older adults found immediate relief from pain, depression, and anxiety, but no direct improvement in sleep. The study suggests that cannabis may improve sleep indirectly by reducing anxiety.

The study on cannabis use among older veterans found that inhaled cannabis use, particularly vaping and dabbing, was associated with cannabis use disorder. The study also revealed that women were more likely to use edibles than men. Future research will focus on the potential adverse health effects of cannabis use, including cardiovascular and mental health outcomes, and whether cannabis serves as a substitute for tobacco smoking.

For this particular episode, key words are: cannabis, older adults, seniors, baby boomers, sleep, THC, CBD, sleep, pain, and ecological momentary assessment.

A study on 100 older adults (55+) found that medical cannabis use provided immediate relief from pain, depression, and anxiety. However, it did not directly improve sleep quality. Instead, improved sleep was associated with reduced anxiety, suggesting an indirect effect of cannabis on sleep through anxiety reduction.

Madison, a PhD student, is researching the effects of medical cannabis use on older adults. Her research, funded by the Consortium for Medical Marijuana Clinical Outcomes Research, explores how different medical cannabis use motives and neurocognitive profiles impact symptoms and mental health. Madison is also investigating ways to promote safe cannabis use among older adults.

Cannabis Boomer podcast aims to educate users about cannabis and its effects, emphasizing the importance of informed consumption. The information shared is based on current scientific opinion and should not be considered medical advice.